LUCILLE D'AGOSTINO: Open Payments
NPI 1477170702 · OGDENSBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 19 payments from 14 companies in 2025. Trend: 2023 $1,064 · 2024 $1,124 · 2025 $702
Food & beverage: $382Education: $320
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $209 |
| Astellas Pharma US Inc | 1 | $92 |
| Incyte Corporation | 2 | $83 |
| Janssen Biotech, Inc. | 1 | $83 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Eisai Inc. | 1 | $34 |
| EMD Serono, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Intera Oncology, Inc | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: Enhertu, DATROWAY, DARZALEX, Lenvima, IMFINZI, JEMPERLI, JAKAFI, INTERA.
Industry payments across NY — which companies pay providers there.
